Incyte

INCY US Health Care Biotechnology
S&P 500
$121.47
-1.47%
Delayed · cached 15 min
Fair Value Analysis →

Frequently asked questions

What sector does Incyte belong to?
Incyte operates in the Health Care sector, specifically the Biotechnology industry, and is listed on the US markets.
What is the current share price of INCY?
As of the latest available quote, INCY traded at $121.47. This price is delayed and cached for about 15 minutes.
What is the P/E ratio of INCY?
Incyte has a price-to-earnings (P/E) ratio of about 15.47. The P/E ratio compares the share price to earnings per share and is most useful when compared with sector peers and the company's own history.
What is the market capitalisation of INCY?
The market capitalisation of Incyte is approximately $24.38B.
Is Incyte profitable?
For its latest reported financial year, Incyte recorded a net profit margin of about 25.03%.
Does INCY pay a dividend?
Incyte does not currently show a dividend yield in our data.
What is the return on equity (ROE) of INCY?
Incyte has a return on equity (ROE) of about 22.88%. ROE measures how much profit a company generates relative to shareholders' equity.
What is the 52-week high and low of INCY?
Over the past 52 weeks, INCY has traded between a low of $81.09 and a high of $132.60.

These answers are generated from reported financial data and live market figures, for educational and informational purposes only.

Educational data only. Not a recommendation to buy, sell or hold any security.